US Pharma MarketingThe blueprint for clinical AI
ARPA-H launched ADVOCATE, funding UpDoc, Tempus AI & Atman Health to build FDA-authorized AI agents for heart failure treatment within 24 months. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push…
ARPA-H, a federal agency that funds breakthrough health technologies, just kicked off a new program called ADVOCATE that provides millions of dollars to health tech companies to build AI agents ...
Source: Endpoints News